40

nanotimes

Companies Facts

tech over the next three years. QLight Nanotech will contribute its experience in nanoparticle research, particularly in synthesizing and manipulating new nanoparticles, and Merck will contribute its experti- se in the specialty materials field and in large-scale production of sophisticated chemical formulations, which will be used for producing large quantities of the nanoparticles developed at QLight Nanotech. http://www.yissum.co.il http://www.Qlightnano.com http://www.youtube.com/watch?v=El4IVLh3sEg

T S

he QinetiQ Group plc (LSE: QQ) published its interim results for the latest six months. The

Group revenues grow 7%, driven by strong sales of survivability products: http://www.qinetiq.com/home/newsroom/news_re-

leases_homepage/2010/4th_quar ter / inter im_re- sults_181110.html

igma-Aldrich (NASDAQ: SIAL) announced a distribution agreement with Nanosys, Inc., an

advanced materials architect. Under the agreement, Sigma-Aldrich, through its Aldrich Materials Science business, is now distributing Nanosys-created silicon nanowires to the global scientific research community for the development of new applications in technologies such as solid-state lighting, electro- nics and energy storage.

“As Aldrich Materials Science continues to expand its nanomaterials offer, we are pleased to introduce an innovative line of silicon nanowires that includes undoped silicon nanowires as well as the higher con- ductivity, boron-doped nanowires,” said Dr. Kaushik Patel, Product Manager, Aldrich Materials Science. “The applications of these nanowires are, we believe,

truly innovative and revolutionary. The fabrication of nanowires is challenging; therefore, a consistent and high-quality supply of these materials from Aldrich Materials Science is expected to enable scientists to accelerate their research to further develop a variety of new high-technology applications that can con- tinue to open up exciting end product markets. In all aspects of the Aldrich Materials Science business, from manufacturing and custom R&D to distribution of materials from leading-edge technology companies such as Nanosys, we strive to fulfill our mission of focusing on materials so that our research customers can focus on results.” http://www.sigma-aldrich.com/newnano http://www.nanosysinc.com

S

ignature Diagnostics AG presented its newest blood-based products for colorectal cancer (CRC)

screening – Detector C and Detector C/Plus – at the 18th United European Gastrointestinal Week (UEGW) Congress in Barcelona end of October 2010. The pa- per, “Early Detection of Colorectal Cancer Based on RNA Measurements in Blood,” was presented by the company‘s CEO, André Rosenthal, Ph.D, at the sessi- on “Colorectal Cancer Screening: New Strategies”.

Signature Diagnostics AG is a molecular diagnostics company based in Potsdam, Germany, focusing on the development and commercialization of novel molecular oncology diagnostic products for early detection (screening) and prognosis of cancer. The Company has completed development of its first two diagnostic products for colorectal cancer screening (Detector C/C+) and prognosis (Predictor C), which will be launched in early 2011 in its own ISO 15189 certified service laboratory. Using its state-of-the- art technologies in tissue and blood sample collec-

10-10/11 :: October/November 2010